References
Stevens A, Milne R, Lilford R, Gabbay J (1999) How do new technologies get into practice? Keeping pace with new technologies: systems needed to identify and evaluate them. Br Med J 319:1291–1294
http://www.phrma.org/files/2008%20Profile.pdf. Accessed December 2008
Joppi R, Bertele' V, Garattini S (2005) Disappointing biotech. Br Med J 331:895–897
Bertele' V, Banzi R, Capasso F, Tafuri G, Trotta F, Apolone G, Garattini S (2007) Haematological anticancer drugs in Europe: any added value at the time of approval? Eur J Clin Pharmacol 63(7):713–719
Garattini S, Bertele’ V (2007) How can we regulate medicines better? Br Med J 335(7624):803–805
Banta HD (1997) Introduction to the EUR-ASSESS report. Int J Technol Assess Health Care 13:133–143
Hailey D, Topfer LA, Willis F (2001) Providing information on emerging health technologies to provincial decision makers: a pilot project. Health Policy 58(1):15–26
Packer C (2005) The National Horizon Scanning Centre (NHSC): early warning for new and emerging health technologies in England. Evidence-Based Healthcare & Public Health 9:410–413
http://www.euroscan.bham.ac.uk. Accessed 10 Feb 2009
Motola D, De Ponti F, Rossi P, Martini N, Montanaro N (2005) Therapeutic innovation in the European Union: analysis of the drugs approved by the EMEA between 1995 and 2003. Br J Clin Pharmacol 59(4):475–478
Motola D, De Ponti F, Poluzzi E, Martini N, Rossi P, Silvani MC, Vaccheri A, Montanaro N (2006) An update on the first decade of the European centralized procedure: how many innovative drugs? Br J Clin Pharmacol 62(5):610–616
Noorani HZ, Huserau DR, Boudreau R (2007) Priority setting for health technology assessments: a systematic review of current practical approaches. Int J Technol Assess Health Care 23(3):310–315
Murphy K, Packer C, Stevens A, Simpson S (2007) Effective early warning systems for new and emerging health technologies: developing an evaluation framework and an assessment of current systems. Int J Technol Assess Health Care 23(3):324–330
Wiviott SD et al (2007) Prasugrel versus clopidogrel in patients with Acute Coronary Syndromes. N Engl J Med 357(20):2001–2015
Wiviott SD et al (2008) Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel thrombolysis in myocardial infarction 38. Circulation 118:1626–1636
http://sanita.cineca.it/public/arno/arnoeng.htm. Accessed 10 Feb 2009
Gershlick AH, Richardson G (2006) Drug eluting stents: dual antiplatelet therapy should not be discontinued without referral to a cardiologist. Br Med J 333:1233–1234
Bhatt DL (2009) Role of antiplatelet therapy across the spectrum of patients with coronary artery disease. Am J Cardiol 103[Suppl 3]:11A–19A
Lee K, Bacchetti P, Sim I. Publication of clinical trials supporting successful new drug applications: a literature analysis. PLoS Med 9:e191. doi:10.1371/journal.pmed.0050191
Rising K, Bacchetti P, Bero L. Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation. PLoS Med 11:e217. doi:10.1371/journal.pmed.0050217
http://www.fda.gov/oc/initiatives/advance/fdaaa.html. Accessed 10 Feb 2009
Konstam MA, Gheorghiade M, Burnett JC Jr et al (2007) Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST outcome trial. JAMA 297(12):1319–1331
Schrier RW, Gross P, Gheorghiade M, Berl T, Verbalis JG, Czerwiec FS, Orlandi C, for the SALT investigators (2006) Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med 355:2099–2112
Acknowledgements
We are grateful to Judith Baggott and Ruth Davis for editorial assistance.
Funding
Institutional funds from the Local Health Unit of Verona, the Veneto Region and the Italian Medicines Agency
Conflict of interest
None
Author information
Authors and Affiliations
Consortia
Corresponding author
Rights and permissions
About this article
Cite this article
Joppi, R., Demattè, L., Menti, A.M. et al. The Italian Horizon Scanning Project. Eur J Clin Pharmacol 65, 775–781 (2009). https://doi.org/10.1007/s00228-009-0666-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-009-0666-z